Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Richard Newitter
TRU
Richard Newitter
Wall Street Analyst
★★★☆☆
#1379
on 13Foresight · ranked by our own returns
54%
Success Rate
+0.7%
Average Return
26 of 48 calls profitable · -3.5% vs benchmark
📈 Across the calls we could measure, roughly 54% of Richard Newitter's ratings turned a profit when each position was held for 1 year — averaging +0.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

138 Buy 81 Hold 0 Sell
Richard's Stock Coverage 47 ratings · 2026-06-19
Company Date Position Consensus Price Target 1-Yr Return
GRDN
Guardian Pharmacy Services, Inc. Class A
Jun 17, 2026 BUY Strong Buy
-1.0% avg upside
7 analysts
$47.00
10.78% Upside
·
IRTC
Irhythm Technologies
Jun 16, 2026 BUY Strong Buy
+62.0% avg upside
19 analysts
·
EW
Edwards Lifesciences
Jun 16, 2026 HOLD Strong Buy
+11.7% avg upside
34 analysts
·
PODD
Insulet
Jun 12, 2026 BUY Strong Buy
+79.3% avg upside
32 analysts
$219.00
50.26% Upside
+0.0%
BSX
Boston Scientific
Jun 04, 2026 BUY Strong Buy
+73.0% avg upside
38 analysts
$64.00
41.39% Upside
-7.2%
MDT
Medtronic
Jun 04, 2026 HOLD Buy
+23.7% avg upside
38 analysts
$86.00
8.35% Upside
-3.2%
GKOS
Glaukos
May 29, 2026 BUY Strong Buy
+5.9% avg upside
20 analysts
·
LNTH
Lantheus
May 26, 2026 BUY Strong Buy
-27.9% avg upside
20 analysts
+4.6%
BBNX
Beta Bionics, Inc.
May 22, 2026 BUY Strong Buy
+53.1% avg upside
13 analysts
+22.9%
DXCM
Dexcom
May 15, 2026 BUY Strong Buy
+38.8% avg upside
32 analysts
+18.7%
SIBN
SI-Bone
May 12, 2026 BUY Strong Buy
+60.9% avg upside
18 analysts
$18.00
13.68% Upside
+1.9%
TMCI
Treace Medical Concepts
May 12, 2026 HOLD Hold
+28.4% avg upside
8 analysts
$2.00
52.27% Downside
·
TNDM
Tandem Diabetes Care
May 11, 2026 BUY Buy
+115.3% avg upside
29 analysts
$31.00
102.58% Upside
+14.4%
GMED
Globus Medical
May 08, 2026 BUY Strong Buy
+22.3% avg upside
24 analysts
+3.1%
VCEL
Vericel
May 08, 2026 BUY Strong Buy
+14.1% avg upside
16 analysts
-1.4%
CARL
Carlsmed, Inc.
May 06, 2026 BUY Strong Buy
+83.2% avg upside
5 analysts
$18.00
78.81% Upside
+11.1%
INSP
Inspire Medical Systems
May 05, 2026 HOLD Buy
+98.0% avg upside
20 analysts
$50.00
17.42% Upside
-12.4%
SYK
Stryker
May 04, 2026 HOLD Strong Buy
+24.1% avg upside
36 analysts
$330.00
7.14% Upside
+4.4%
ITGR
Integer Holdings
May 01, 2026 BUY Buy
+6.6% avg upside
15 analysts
+7.6%
PRCT
PROCEPT BioRobotics
Apr 30, 2026 BUY Buy
+81.6% avg upside
16 analysts
-7.0%
ZBH
Zimmer Biomet Holdings
Apr 29, 2026 HOLD Buy
+27.6% avg upside
37 analysts
$92.00
4.63% Upside
+10.8%
ISRG
Intuitive Surgical
Apr 22, 2026 BUY Strong Buy
+29.5% avg upside
36 analysts
$580.00
42.54% Upside
-13.8%
IART
Integra Lifesciences
Apr 15, 2026 HOLD Buy
+137.0% avg upside
21 analysts
$12.00
31.75% Downside
+59.6%
TFX
Teleflex
Mar 04, 2026 HOLD Buy
+42.3% avg upside
19 analysts
$135.00
6.30% Upside
+7.1%
KIDS
OrthoPediatrics
Mar 02, 2026 HOLD Strong Buy
+60.6% avg upside
10 analysts
$20.00
5.98% Upside
-7.3%
MBX
MBX Biosciences, Inc.
Jan 16, 2026 BUY Strong Buy
+54.0% avg upside
14 analysts
-1.1%
PEN
Penumbra
Jan 16, 2026 HOLD Buy
+4.5% avg upside
23 analysts
$374.00
17.97% Upside
-9.5%
KYMR
Kymera Therapeutics
Jun 26, 2025 BUY Strong Buy
+9.0% avg upside
36 analysts
+87.2%
RXO
RXO, Inc.
Jun 18, 2025 BUY Hold
-24.0% avg upside
25 analysts
+20.9%
JAZZ
Jazz Pharmaceuticals
Oct 16, 2024 BUY Strong Buy
-1.8% avg upside
35 analysts
+16.1%
KROS
Keros Therapeutics
Jun 20, 2024 BUY Strong Buy
+139.8% avg upside
21 analysts
-70.3%
PGNY
Progyny
Apr 17, 2024 BUY Strong Buy
+11.9% avg upside
14 analysts
-34.5%
MMM
3M
Aug 22, 2023 HOLD Buy
+3.2% avg upside
24 analysts
$148.00
7.78% Downside
+62.3%
ORGO
Organogenesis Holdings
Oct 07, 2021 BUY Strong Buy
+385.9% avg upside
8 analysts
-74.4%
RXST
RxSight
Sep 10, 2021 BUY Hold
+133.2% avg upside
13 analysts
$20.00
322.79% Upside
+5.3%
CH:ALC
Alcon
Aug 17, 2021 HOLD Buy
+34.9% avg upside
35 analysts
$64.98
25.12% Upside
·
A
Agilent
Aug 06, 2021 BUY Strong Buy
+3.9% avg upside
32 analysts
-13.7%
AXGN
AxoGen
Aug 05, 2021 BUY Strong Buy
-25.8% avg upside
21 analysts
$27.00
39.81% Downside
-45.5%
LNSR
LENSAR
Aug 05, 2021 BUY Strong Buy
+110.9% avg upside
4 analysts
$20.00
248.43% Upside
-24.4%
BDX
Becton Dickinson
Aug 05, 2021 HOLD Buy
+35.6% avg upside
25 analysts
$250.00
73.61% Upside
+8.6%
CNMD
Conmed
Jul 28, 2021 HOLD Hold
+81.5% avg upside
12 analysts
$141.00
332.79% Upside
-27.9%
ALGN
Align Tech
Jul 28, 2021 BUY Strong Buy
+58.0% avg upside
21 analysts
$770.00
322.81% Upside
-54.6%
ATRC
Atricure
Jul 15, 2016 BUY Strong Buy
+59.3% avg upside
12 analysts
$20.00
30.64% Downside
+59.5%
SENS
Senseonics Holdings
Jul 15, 2016 BUY Buy
+125.2% avg upside
13 analysts
$4.50
33.32% Downside
-41.3%
JNJ
Johnson & Johnson
Jul 15, 2016 BUY Strong Buy
-3.6% avg upside
36 analysts
$140.00
38.63% Downside
+10.7%
BAX
Baxter International
Jul 15, 2016 HOLD Hold
+50.4% avg upside
23 analysts
$47.00
136.21% Upside
+34.3%
ABT
Abbott Laboratories
Jul 15, 2016 HOLD Strong Buy
+31.2% avg upside
35 analysts
$45.00
49.05% Downside
+19.1%
🔒 42 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Richard Newitter — Frequently Asked Questions
How accurate are Richard Newitter's stock ratings?
Based on the calls 13Foresight could measure, about 54% of Richard's ratings were profitable over a one-year hold, with an average return of +0.7% per rating, or -3.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Richard ranked on 13Foresight?
Richard Newitter is currently ranked #1379 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Richard cover?
Richard most recently has ratings on GRDN, IRTC, EW, PODD, BSX, MDT, GKOS, LNTH, BBNX, DXCM, SIBN, TMCI and 35 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.